Baxter International Inc. · NYSE:BAX
Baxter International — Shareholder Meeting (April 2020)
17 slides from Baxter International's shareholder meeting presentation, April 2020
Slide 1: Annual Meeting Shareholder Engagement
Fall Shareholder Engagement August 2019 Annual Meeting Shareholder Engagement Baxter International Inc. April 2020
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter’s financial results, business development activities, corporate governance goals, compensation program, COVID-19 response efforts and remediation efforts following the internal investigation related to fore
Slide 3: Executive Summary
Executive Summary COVID-19 Maximizing production of critical medical products to support increased patient care levels Protecting employee health and safety through enhanced infection control procedures Response Creating up to 2,000 new positions globally, including 800 in the U.S. Efforts D
Slide 4: Committed Response To The COVID-19 Pandemic
Committed Response To The COVID-19 Pandemic • Boosted capacity and production to address higher demand for: PrisMax and Prismaflex and associated solutions and consumables; Mini-Bag Plus; Spectrum IQ Infusion System and accompanying I.V. sets; I.V. solutions; and injectable drugs Increasing Product
Slide 5: Baxter: A Leading Medical Products Company
Baxter: A Leading Medical Products Company Baxter’s mission to save and sustain lives inspires our work and our commitment to deliver products and services that are essential building blocks of healthcare. Global Footprint 2019 Revenue | $11.4B By Global Business By Operating Manufacturing 100+ faci
Slide 6: Top Quartile Goals Our Strategy
Top Quartile Goals Product safety and Quality Best place to work Growth through innovation Industry leading performance Our Strategy Strengthen our portfolio and extend our impact through transformative innovation that spans prevention to recovery 6
Slide 7: Executing On Our Strategy: Recent Highlights
Executing On Our Strategy: Recent Highlights Providing Frontline Support And Maintaining Global Supply In Light Of COVID-19 Pandemic Taking proactive measures to protect employee workplace safety, provide aid to healthcare providers and those affected by pandemic, and maintain global supply; conti
Slide 8: Continuing Momentum of Key Performance Metrics
Continuing Momentum of Key Performance Metrics1 Global Reported Sales Adjusted Operating Margin Adjusted Diluted EPS ~$11.1B ~$11.4B 17.3% 18.7% $2.91 $3.31 +5% Operational Growth2 +140 bps +14% FY 2018 FY 2019 FY 2018 FY 2019 FY 2018 FY 2019 as restated as restated as restated Delivering Significan
Slide 9: Internal Investigation and Restatement
Internal Investigation and Restatement Board Oversight Executive Compensation Decisions ► In October 2019, the Company announced that it had commenced an internal investigation into certain intra-company transactions that Recoupment Policy impacted its previously reported non-operating foreign excha
Slide 10: Affirmative Steps to Enhance Internal Control
Affirmative Steps to Enhance Internal Control The Audit Committee continues to monitor the Company’s activities to remediate the material weakness related to foreign exchange gains and losses. The Company has already commenced comprehensive remediation actions, including: ► Discontinued use of histo
Slide 11: Director Skillsets Support Effective Oversight of Strategy
Director Skillsets Support Effective Oversight of Strategy Our Board possesses the collective knowledge and experience to effectively oversee the execution of Baxter’s long-term strategy Complementary Skillsets JOSE (JOE) ALMEIDA THOMAS F. CHEN JOHN D. FORSYTH Chairman, President & CEO Former SV
Slide 12: Independent Board Leadership and Sound Board Practices
Independent Board Leadership and Sound Board Practices Effective Board Leadership and Independent Oversight ► Experience, expertise and knowledge represented collectively by the Board allow it to effectively serve shareholders’ interests ► Independent Lead Director elected annually by independent di
Slide 13: Strong Governance and Compensation Practices
Strong Governance and Compensation Practices Our Board has adopted strong governance and compensation practices to provide stockholders with meaningful rights and to help ensure long-term focus and appropriate levels of risk-taking Governance Compensation ► Annual election of directors ► Pay-for-per
Slide 14: Executive Compensation Aligned with Strategic Priorities
Executive Compensation Aligned with Strategic Priorities A significant majority of executive pay is “at risk” and only delivered if specific annual and long-term performance requirements are met Pay Element Objectives CEO Pay Mix (2019) Provides a base level of competitive compensation Salary Us
Slide 15: Compensation Program Reflects Stockholder Feedback
Compensation Program Reflects Stockholder Feedback Informed by stockholder feedback from prior stockholder outreach discussions, the Compensation Committee made the following changes to its 2019 or 2020 executive compensation programs: Restricted Stock Units (RSUs) • Company did not issue any RSUs t
Slide 16: Demonstrating Leadership In Corporate Social Responsibility
Demonstrating Leadership In Corporate Social Responsibility Baxter 2020 Corporate Responsibility Priorities and Goals PRODUCT INNOVATION WORKPLACE CULTURE ETHICS AND COMPLIANCE EMPLOYEE HEALTH & SAFETY Improve sustainability and Promote inclusion, diversity and Drive a culture of integrity and the A
Slide 17: A Recognized Top Employer and Outstanding Corporate Citizen
A Recognized Top Employer and Outstanding Corporate Citizen Serving Our Recent Highlights Communities Worldwide Reducing Our Environmental Footprint Expanding Access To Care Focusing On Inclusion and For more information on Baxter’s efforts to benefit our communities, employees, Diversity and stakeh
Baxter International — Shareholder Meeting (April 2020) on 6ix